Greg Harrison Analyst PerformanceAnalyst at Bank of AmericaGreg Harrison is a stock analyst at Bank of America in the medical sector, covering 17 publicly traded companies. Over the past year, Greg Harrison has issued 34 stock ratings, including strong buy, buy, and hold recommendations. While full access to Greg Harrison's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Greg Harrison's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings38 Last 1 YearsBuy Recommendations71.05% 27 Buy RatingsCompanies Covered17 Unique Companies Ratings Distribution38RatingsDistribution of strong buy, buy, hold, and sell ratings by Greg Harrison.RatingPercentageCount Strong Buy2.6%1 ratings Buy68.4%26 ratings Hold28.9%11 ratings Sell0.0%0 ratingsOut of 38 total stock ratings issued by Greg Harrison at Bank of America, the majority (68.4%) have been Buy recommendations, followed by 28.9% Hold and 2.6% Strong Buy.Best & Worst CallsBest Call0000.0%LQDAMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call00.0%AGIOMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ17 companiesGreg Harrison, an analyst at Bank of America, currently covers 17 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical17 companies100.0%Greg Harrison of Bank of America specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE14 companies82.4%MED - DRUGS2 companies11.8%MED - GENERIC DRG1 company5.9% Greg Harrison's Ratings History at Bank of America Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAGIOAgios Pharmaceuticals4/21/2026Lower Price Target$26.65$41.00Buy$0.0000.00% ROIUTHRUnited Therapeutics3/31/2026Boost Price Target$588.36$626.00Neutral$0.0000.00% ROIMLYSMineralys Therapeutics3/13/2026Boost Price Target$27.60$51.00Buy$0.0000.00% ROINTLAIntellia Therapeutics3/2/2026Reiterated Rating$15.13Neutral$0.0000.00% ROIUTHRUnited Therapeutics2/25/2026Reiterated Rating$535.10Neutral$0.0000.00% ROIAGIOAgios Pharmaceuticals12/24/2025Boost Price Target$24.59$34.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals11/20/2025Lower Price Target$22.34$32.00Buy$0.0000.00% ROIVRTXVertex Pharmaceuticals11/13/2025Initiated Coverage$437.67$495.00Sector Outperform$0.0000.00% ROIVRTXVertex Pharmaceuticals11/12/2025Upgrade$434.52Strong-Buy$0.0000.00% ROINTLAIntellia Therapeutics10/27/2025Lower Price Target$14.79$30.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. UTHRUnited Therapeutics9/2/2025Boost Price Target$409.21$463.00Neutral$0.0000.00% ROIMLYSMineralys Therapeutics8/28/2025Boost Price Target$15.29$43.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals8/20/2025Upgrade$3.66$10.00Buy$0.0000.00% ROITVTXTravere Therapeutics8/7/2025Boost Price Target$16.79$31.00Sector Outperform$0.0000.00% ROIOCULOcular Therapeutix8/6/2025Lower Price Target$12.35$20.00Sector Outperform$0.0000.00% ROIBBIOBridgeBio Pharma8/6/2025Boost Price Target$43.74$57.00Sector Outperform$0.0000.00% ROIVRTXVertex Pharmaceuticals8/5/2025Lower Price Target$392.94$438.00Sector Perform$0.0000.00% ROIALNYAlnylam Pharmaceuticals8/1/2025Boost Price Target$401.80$450.00Sector Outperform$0.0000.00% ROIAGIOAgios Pharmaceuticals7/28/2025Lower Price Target$37.20$65.00Sector Outperform$0.0000.00% ROIRCKTRocket Pharmaceuticals7/25/2025Reiterated Rating$3.21$4.00Neutral$0.0000.00% ROIAGIOAgios Pharmaceuticals7/22/2025Lower Price Target$39.54$51.00Buy$0.0000.00% ROIGOSSGossamer Bio7/14/2025Initiated Coverage$1.36$11.00Sector Outperform$0.0000.00% ROIUTHRUnited Therapeutics6/11/2025Lower Price Target$278.95$315.00Neutral$0.0000.00% ROIVERAVera Therapeutics6/2/2025Set Price Target$30.98$65.00Sector Outperform$0.0000.00% ROIARCTArcturus Therapeutics5/28/2025Initiated Coverage$11.87$32.00Sector Outperform$0.0000.00% ROIRCKTRocket Pharmaceuticals5/28/2025Lower Price Target$2.41$19.00Sector Outperform$0.0000.00% ROILQDALiquidia5/28/2025Boost Price Target$14.70$37.00Sector Outperform$0.0000.00% ROIRCKTRocket Pharmaceuticals5/28/2025Lower Price Target$2.51$9.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals5/12/2025Lower Price Target$7.16$51.00Sector Outperform$0.0000.00% ROIKROSKeros Therapeutics5/12/2025Lower Price Target$13.52$26.00Sector Outperform$0.0000.00% ROIGERNGeron5/8/2025Downgrade$1.31$1.50Sector Perform$0.0000.00% ROIAPLSApellis Pharmaceuticals5/8/2025Lower Price Target$17.49$20.00Sector Perform$0.0000.00% ROIVRTXVertex Pharmaceuticals5/6/2025Lower Price Target$434.64$442.00Sector Perform$0.0000.00% ROILQDALiquidia5/5/2025Boost Price Target$16.30$36.00Sector Outperform$00.0000.00% ROIAGIOAgios Pharmaceuticals5/2/2025Lower Price Target$31.18$71.00Sector Outperform$00.0000.00% ROIBBIOBridgeBio Pharma4/30/2025Boost Price Target$38.50$55.00Sector Outperform$00.0000.00% ROIUTHRUnited Therapeutics4/21/2025Upgrade$284.73$314.00Neutral$000.0000.00% ROITVTXTravere Therapeutics4/1/2025Boost Price Target$17.92$31.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
